Filter
555
Text search:
drug
market
Featured
Recommendations
49
New Publications
153
Language
Document type
No document type
300
Studies & Reports
113
Guidelines
72
Strategic & Response Plan
32
Manuals
20
Fact sheets
8
Training Material
6
Situation Updates
2
App
1
Resource Platforms
1
Countries / Regions
India
28
Kenya
24
Ethiopia
22
Global
22
Ghana
17
Uganda
15
South Africa
15
Western and Central Europe
15
Malawi
12
Myanmar / Burma
10
Nigeria
9
Philippines
8
Zambia
8
Tanzania
8
Senegal
7
Cambodia
7
Rwanda
7
Africa
7
Sierra Leone
6
Zimbabwe
6
Syria
6
Asia
6
Nepal
5
Botswana
5
South–East Asia Region
5
Venezuela
5
Eastern Europe
5
Bangladesh
4
Ukraine
4
Latin America and the Carribbean
4
Liberia
3
Congo, Democratic Republic of
3
Cameroon
3
Mozambique
3
Sudan
3
East and Southern Africa
3
South Sudan
2
Lebanon
2
Thailand
2
Indonesia
2
Brazil
2
Hungary
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Russia
2
Moldova
2
Georgia
2
Morocco
1
USA
1
Haiti
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Papua New Guinea
1
Argentina
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Colombia
1
Lesotho
1
Mexico
1
Sri Lanka
1
Fiji
1
Poland
1
Palestine
1
Albania
1
Laos
1
Timor Leste/ East Timor
1
Estonia
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
232
Clinical Guidelines
40
Public Health
29
Key Resources
22
Women & Child Health
16
Pharmacy & Technologies
16
Capacity Building
5
Toolboxes
HIV
58
AMR
54
Mental Health
41
TB
38
Pharmacy
33
COVID-19
32
Conflict
13
NTDs
12
Planetary Health
10
NCDs
8
Disability
7
Refugee
6
Global Health Education
6
Ebola & Marburg
5
Cholera
5
Caregiver
5
Malaria
5
Rapid Response
4
Health Financing Toolbox
4
Specific Hazards
3
Social Ethics
2
2.0 Rapid Response
2
Polio
1
Natural Hazards
1
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also re
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first c
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug u
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have lea
...
Volume 20, September
Global smart update
Strategic Overview
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Southern Med Review (2009)2;1:2-6
Revised Edition
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.